Zenas BioPharma, Inc. Common Stock Defensive Interval Ratio
Zenas BioPharma, Inc. Common Stock defensive interval ratio. Zenas BioPharma, Inc. Common Stock (ZBIO) has a Defensive Interval Ratio of 2481 days as of June 2026. Defensive assets of $447.35 Million (cash $-, short-term investments $446.55 Million, receivables $800.00K) cover 2481 days of daily cash needs of $180.32K/day. See ZBIO net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Defensive Interval Ratio of Zenas BioPharma, Inc. Common Stock (2023–2025)
Defensive interval ratio of Zenas BioPharma, Inc. Common Stock from 2023 to 2025. This chart shows how Zenas BioPharma, Inc. Common Stock's Defensive Interval Ratio has evolved across 3 annual periods from 2023 to 2025. As of June 2026, the ratio stands at 2481 days, meaning defensive assets of $447.35 Million can fund 2481 days of operations without new revenue. Check how resilient are Zenas BioPharma, Inc. Common Stock's assets to evaluate the company's liquid asset resilience ratio.
Zenas BioPharma, Inc. Common Stock Defensive Interval Ratio by Year (2023–2025)
Zenas BioPharma, Inc. Common Stock defensive interval ratio by year from 2023 to 2025. The table below presents the year-by-year Defensive Interval Ratio for Zenas BioPharma, Inc. Common Stock from 2023 to 2025, covering 3 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Zenas BioPharma, Inc. Common Stock asset portfolio.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 1355 days | $232.55 Million | $171.64K/day | $- | $232.55 Million | ▲ +1157 days |
| 2024 | 198 days | $31.02 Million | $156.96K/day | $- | $31.02 Million | ▲ +198 days |
| 2023 | 0 days | $0.00 | $63.72K/day | $- | $0.00 | — |